Tempus AI, Inc. (NASDAQ:TEM) Director Sells $3,075,600.00 in Stock

Key Points

• Theodore Leonsis, a director at Tempus AI, sold 44,000 shares of the company's stock for a total of $3,075,600, resulting in a 33.65% decrease in his ownership.
• Tempus AI reported a revenue increase of 89.5% year-over-year for the last quarter, totaling $314.64 million, and delivered an earnings per share (EPS) of ($0.22), beating expectations by $0.01.
• Several institutions increased their stakes in Tempus AI, with 24.22% of the company's stock now owned by institutional investors, reflecting strong interest in the company.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) Director Theodore Leonsis sold 44,000 shares of Tempus AI stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $69.90, for a total transaction of $3,075,600.00. Following the completion of the sale, the director directly owned 86,756 shares of the company's stock, valued at $6,064,244.40. The trade was a 33.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Theodore Leonsis also recently made the following trade(s):

• On Wednesday, June 11th, Theodore Leonsis sold 205,847 shares of Tempus AI stock. The stock was sold at an average price of $67.66, for a total transaction of $13,927,608.02.

Tempus AI Stock Performance

TEM traded up $2.19 on Friday, hitting $73.78. 14,646,490 shares of the company's stock were exchanged, compared to its average volume of 10,221,011. The firm has a market cap of $12.77 billion, a PE ratio of -62.00 and a beta of 4.98. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $91.45. The stock has a fifty day moving average of $63.13 and a two-hundred day moving average of $58.57. The company has a current ratio of 1.54, a quick ratio of 1.56 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same quarter last year, the business earned ($6.86) earnings per share. Tempus AI's revenue was up 89.5% compared to the same quarter last year. On average, research analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tempus AI

Large investors have recently made changes to their positions in the company. Pathway Capital Management LP bought a new position in shares of Tempus AI in the first quarter valued at approximately $8,576,000. Wells Fargo & Company MN boosted its stake in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares during the period. SeaCrest Wealth Management LLC acquired a new position in Tempus AI in the 1st quarter worth approximately $535,000. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after purchasing an additional 1,016,384 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in Tempus AI by 92.6% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company's stock worth $27,926,000 after purchasing an additional 278,311 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on TEM. Bank of America boosted their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Morgan Stanley boosted their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research note on Tuesday. Guggenheim boosted their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Finally, BTIG Research assumed coverage on Tempus AI in a report on Friday, August 8th. They issued a "buy" rating and a $60.00 price objective for the company. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI currently has a consensus rating of "Moderate Buy" and a consensus target price of $65.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.